ARCHIVES

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | March 27, 1998

Download PDF Visit The Full Archive

Related Articles

Zydelig Tablets Approved For Three Blood Cancers

July 25, 2014

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014

Conferees Agree On 6,200 Grants For NIH This Year

August 2, 1985

CCRU-CCSP Report At Closed Session “Declassified” Discusses Review

December 3, 1982

FDA Hazleton Probe Finds Some Problems; Results Unaffected

April 23, 1976

Pharmacia Letter Announces Suspension Of Two Trials.

May 11, 2001